title: Reply: To PMID 23518900.
authors.affiliation: Retina Macula Institute and the Retina Macula Research Center, Torrance, California.
authors.forename: Behnam
authors.initials: B
authors.lastname: Sharareh
authors.forename: Ron P
authors.initials: RP
authors.lastname: Gallemore
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012170:Retinal Vein Occlusion / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D003907:Dexamethasone